array:25 [
  "pii" => "S2013251418301445"
  "issn" => "20132514"
  "doi" => "10.1016/j.nefroe.2018.11.009"
  "estado" => "S300"
  "fechaPublicacion" => "2018-11-01"
  "aid" => "5001"
  "copyright" => "Sociedad Española de Nefrología"
  "copyrightAnyo" => "2018"
  "documento" => "simple-article"
  "crossmark" => 0
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "cor"
  "cita" => "Nefrologia (English Version). 2018;38:672-3"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 991
    "formatos" => array:3 [
      "EPUB" => 154
      "HTML" => 431
      "PDF" => 406
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:20 [
      "pii" => "S0211699518300791"
      "issn" => "02116995"
      "doi" => "10.1016/j.nefro.2018.04.005"
      "estado" => "S300"
      "fechaPublicacion" => "2018-11-01"
      "aid" => "501"
      "copyright" => "Sociedad Española de Nefrología"
      "documento" => "simple-article"
      "crossmark" => 0
      "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
      "subdocumento" => "cor"
      "cita" => "Nefrologia. 2018;38:672-3"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 2352
        "formatos" => array:3 [
          "EPUB" => 236
          "HTML" => 1466
          "PDF" => 650
        ]
      ]
      "es" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Carta al Director</span>"
        "titulo" => "Trasplantar receptores hepatitis C negativos con ri&#241;ones de donantes seropositivos&#46; &#191;Por qu&#233; no&#63;"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "672"
            "paginaFinal" => "673"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Transplantation of hepatitis C infected kidneys into uninfected recipients&#46; Why not&#63;"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Antonio Franco, Noelia Balibrea, Angelina Gimeno, Esperanza Merino, Maria Isabel Lopez, Carlos Santiago, Francisco Perez Contreras"
            "autores" => array:7 [
              0 => array:2 [
                "nombre" => "Antonio"
                "apellidos" => "Franco"
              ]
              1 => array:2 [
                "nombre" => "Noelia"
                "apellidos" => "Balibrea"
              ]
              2 => array:2 [
                "nombre" => "Angelina"
                "apellidos" => "Gimeno"
              ]
              3 => array:2 [
                "nombre" => "Esperanza"
                "apellidos" => "Merino"
              ]
              4 => array:2 [
                "nombre" => "Maria Isabel"
                "apellidos" => "Lopez"
              ]
              5 => array:2 [
                "nombre" => "Carlos"
                "apellidos" => "Santiago"
              ]
              6 => array:2 [
                "nombre" => "Francisco"
                "apellidos" => "Perez Contreras"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S2013251418301445"
          "doi" => "10.1016/j.nefroe.2018.11.009"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251418301445?idApp=UINPBA000064"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0211699518300791?idApp=UINPBA000064"
      "url" => "/02116995/0000003800000006/v2_201812130605/S0211699518300791/v2_201812130605/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S2013251418301329"
    "issn" => "20132514"
    "doi" => "10.1016/j.nefroe.2018.11.004"
    "estado" => "S300"
    "fechaPublicacion" => "2018-11-01"
    "aid" => "492"
    "copyright" => "Sociedad Espa&#241;ola de Nefrolog&#237;a"
    "documento" => "simple-article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "cor"
    "cita" => "Nefrologia &#40;English Version&#41;. 2018;38:674-5"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1394
      "formatos" => array:3 [
        "EPUB" => 151
        "HTML" => 758
        "PDF" => 485
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>"
      "titulo" => "Podocytopathy as the onset of systemic lupus erythematosus"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "674"
          "paginaFinal" => "675"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Podocitopat&#237;a como inicio de un lupus eritematoso sist&#233;mico"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Fig&#46; 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1567
              "Ancho" => 2119
              "Tamanyo" => 142512
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Evolution of proteinuria and serum albumin with the treatment&#46;</p> <p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">MMF&#58; mycophenolate mofetil&#59; Pd&#58; prednisone&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Salom&#233; Muray Cases, Mar&#237;a Teresa Herranz Mar&#237;n, Concepci&#243;n Alc&#225;zar Fajardo, Alberto Javier Andreu Mu&#241;oz, Juan B&#46; Cabezuelo Romero"
          "autores" => array:5 [
            0 => array:2 [
              "nombre" => "Salom&#233;"
              "apellidos" => "Muray Cases"
            ]
            1 => array:2 [
              "nombre" => "Mar&#237;a Teresa"
              "apellidos" => "Herranz Mar&#237;n"
            ]
            2 => array:2 [
              "nombre" => "Concepci&#243;n"
              "apellidos" => "Alc&#225;zar Fajardo"
            ]
            3 => array:2 [
              "nombre" => "Alberto Javier"
              "apellidos" => "Andreu Mu&#241;oz"
            ]
            4 => array:2 [
              "nombre" => "Juan B&#46;"
              "apellidos" => "Cabezuelo Romero"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251418301329?idApp=UINPBA000064"
    "url" => "/20132514/0000003800000006/v1_201812140610/S2013251418301329/v1_201812140610/en/main.assets"
  ]
  "itemAnterior" => array:20 [
    "pii" => "S2013251418301287"
    "issn" => "20132514"
    "doi" => "10.1016/j.nefroe.2018.11.001"
    "estado" => "S300"
    "fechaPublicacion" => "2018-11-01"
    "aid" => "486"
    "copyright" => "Sociedad Espa&#241;ola de Nefrolog&#237;a"
    "documento" => "simple-article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "cor"
    "cita" => "Nefrologia &#40;English Version&#41;. 2018;38:671-2"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 761
      "formatos" => array:3 [
        "EPUB" => 148
        "HTML" => 298
        "PDF" => 315
      ]
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>"
      "titulo" => "Successful treatment of chronic hepatitis C in a kidney transplant patient with only 2 weeks of direct-acting antiviral therapy"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "671"
          "paginaFinal" => "672"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Eficacia del tiempo de tratamiento ultracorto con terapia antiviral de acci&#243;n directa para la hepatitis C cr&#243;nica en un paciente con trasplante de ri&#241;&#243;n&#58; reporte de un caso"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Sofia de S&#225; Guimar&#227;es Cerqueira, M&#243;nica Dinis Mesquita, Rui Arlindo Castro, Paulo Carrola, Teresa Margarida Pinto Ribeiro Morgado, Paula Marques"
          "autores" => array:6 [
            0 => array:2 [
              "nombre" => "Sofia"
              "apellidos" => "de S&#225; Guimar&#227;es Cerqueira"
            ]
            1 => array:2 [
              "nombre" => "M&#243;nica Dinis"
              "apellidos" => "Mesquita"
            ]
            2 => array:2 [
              "nombre" => "Rui Arlindo"
              "apellidos" => "Castro"
            ]
            3 => array:2 [
              "nombre" => "Paulo"
              "apellidos" => "Carrola"
            ]
            4 => array:2 [
              "nombre" => "Teresa Margarida Pinto Ribeiro"
              "apellidos" => "Morgado"
            ]
            5 => array:2 [
              "nombre" => "Paula"
              "apellidos" => "Marques"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S021169951830064X"
        "doi" => "10.1016/j.nefro.2018.03.002"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S021169951830064X?idApp=UINPBA000064"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251418301287?idApp=UINPBA000064"
    "url" => "/20132514/0000003800000006/v1_201812140610/S2013251418301287/v1_201812140610/en/main.assets"
  ]
  "en" => array:13 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>"
    "titulo" => "Transplantation of hepatitis C infected kidneys into uninfected recipients&#46; Why not&#63;"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "672"
        "paginaFinal" => "673"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Antonio Franco, Noelia Balibrea, Angelina Gimeno, Esperanza Merino, Maria Isabel Lopez, Carlos Santiago, Francisco Perez Contreras"
        "autores" => array:7 [
          0 => array:4 [
            "nombre" => "Antonio"
            "apellidos" => "Franco"
            "email" => array:1 [
              0 => "franco&#95;ant&#64;gva&#46;es"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Noelia"
            "apellidos" => "Balibrea"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "Angelina"
            "apellidos" => "Gimeno"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "Esperanza"
            "apellidos" => "Merino"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
            ]
          ]
          4 => array:3 [
            "nombre" => "Maria Isabel"
            "apellidos" => "Lopez"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          5 => array:3 [
            "nombre" => "Carlos"
            "apellidos" => "Santiago"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          6 => array:3 [
            "nombre" => "Francisco"
            "apellidos" => "Perez Contreras"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:3 [
          0 => array:3 [
            "entidad" => "Servicio de Nefrolog&#237;a&#44; Hospital General Universitario Alicante&#44; Alicante&#44; Spain"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Servicio de Microbiolog&#237;a&#44; Hospital General Universitario Alicante&#44; Alicante&#44; Spain"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "Servicio de Medicina Interna&#44; Hospital General Universitario Alicante&#44; Alicante&#44; Spain"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "<span class="elsevierStyleItalic">Corresponding author</span>&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Trasplantar receptores hepatitis C negativos con ri&#241;ones de donantes seropositivos&#46; &#191;Por qu&#233; no&#63;"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">The enemy to beat is the hepatitis C virus &#40;HCV&#41;&#44; a RNA virus of 30&#8211;38<span class="elsevierStyleHsp" style=""></span>nm in size with icosahedral coat&#46; It is a Hepacivirus of the Flaviviridae family&#44; which has 7 genotypes&#46;<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">1</span></a> Its transmission is parenteral&#44; therefore its transmission through transplanted organs has been well documented and it causes acute and chronic hepatitis&#46;<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">2</span></a> Given this risk&#44; transplant from donors with antibodies against HCV has been totally contraindicated in noninfected recipients&#46; It is estimated that more than 500 high quality kidney grafts are discarded annually in the USA for this reason&#46;<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">3</span></a> In 2016 we did not transplanted 15 kidneys for this reason&#46;<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">4</span></a><span class="elsevierStyleSup">&#46;</span> A number of organs could be transplanted to recipients infected with HCV&#46;<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">5</span></a> The efficacy of direct-acting antivirals eliminated HCV patients from the waiting lists<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">6</span></a> making possible the use these organs&#44; in a society clearly need them&#46;<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">4</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">At present we have tools to change this panorama that have been clearly stated in the Hepatitis C Consensus Conference of the American Society of Transplantion&#46;<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">7</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">The risk of HCV transmission must be defined&#59; there is a clear distinction between donor carrying antibodies&#44; not necessarily infectious&#44; and the patient with viraemia that is infective&#46; To carry out this separation&#44; we use the Xpert&#174; HCV Viral Load test with the Cepheid GeneXpert&#174; system &#40;distributed by Werfen&#41;&#44; available in our hospital&#44; that quantifies the viral load in 1<span class="elsevierStyleHsp" style=""></span>h which allows the quick identification of the infective donor&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">The efficacy&#44; safety and tolerability of direct antivirals make feasible the transplantation of viraemic donors in seronegative recipients&#46; Even more now with the current commercialization of the compounds glecaprevir and pibrentasvir effective against all genotypes&#44; so there is no need to identify the genotype of the donor and are not contraindicated in renal failure&#44; which allows its use in the peritransplant period&#46;<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">8</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">Having these tools and the successful experiences by Durand et al&#46;<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">9</span></a> and Goldberg et al&#46;<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">10</span></a> this year&#44; we requested an ethical evaluation to implement an action protocol &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41; to the bioethics committee of our hospital&#44; which gave its approval on July 18&#44; 2017 and stressed the importance of explaining to the recipient the procedure for the subsequent signing of an informed consent&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0030" class="elsevierStylePara elsevierViewall">In the application of the protocol of action &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41;&#44; we transplanted 2 seronegative male HCV recipients of 45 and 58 years with grafts from a 40-year-old female donor and a 57-year-old male both seropositive&#44; but with negative viral load&#44; for what we apply the action 1&#46; The patients today are carriers of a functioning graft and the viral load in them has been repeatedly negative&#46;</p><p id="par0035" class="elsevierStylePara elsevierViewall">Our initial experience&#44; endorsed by other teams&#44; should encourage the extensive&#44; albeit meticulous&#44; use of this type of donors and lead us to the conclusion that HCV&#44; the enemy to beat&#44; is very likely beaten&#46;</p></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; Franco A&#44; Balibrea N&#44; Gimeno A&#44; Merino E&#44; Lopez MI&#44; Santiago C&#44; et al&#46; Trasplantar receptores hepatitis C negativos con ri&#241;ones de donantes seropositivos&#46; &#191;Por qu&#233; no&#63; Nefrologia&#46; 2018&#46; <a class="elsevierStyleInterRef" target="_blank" id="intr0005" href="https://doi.org/10.1016/j.nefro.2018.04.005">https&#58;&#47;&#47;doi&#46;org&#47;10&#46;1016&#47;j&#46;nefro&#46;2018&#46;04&#46;005</a></p>"
      ]
    ]
    "multimedia" => array:1 [
      0 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Table 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Table "
            "rol" => "short"
          ]
        ]
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleBold">Donor to include&#58;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Carriers of HCV antibodies</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">No drug addiction or institutionalization</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Rapid assessment of viral load</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Absent viral load&#58; acting group 1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Viral load present&#58; action group 2&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleBold">Recipients to include&#58;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Individualization</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Personal interview</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Signing of an informed consent&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleBold">Action to follow&#58;</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Action 1&#58; considered non-infective</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Standard renal TX&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Biweekly viral load quantification&#47;3 months&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Positive&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Glecaprevir 300<span class="elsevierStyleHsp" style=""></span>mg&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Pibrentasvir 120<span class="elsevierStyleHsp" style=""></span>mg&#47;12 weeks&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Negative&#58; no treatment&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleBold">Action 2&#58; considered infective</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Pre-tx and post-tx</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">or Glecaprevir 300</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">mg</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">or Pibrentasvir 120</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">mg&#47;12 weeks</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab1921430.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Action protocol&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:10 [
            0 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:3 [
                  "comentario" => "&#91;accessed 1 Dec 2017&#93; Available in&#58; http&#58;&#47;&#47;jvi&#46;asm&#46;org&#47;cgi&#47;doi&#47;10&#46;1128&#47;JVI&#46; 00526-10"
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Ultrastructural and biophysical characterization of hepatitis C virus particles produced in cell culture"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "P&#46; Gastaminza"
                            1 => "K&#46;A&#46; Dryden"
                            2 => "B&#46; Boyd"
                            3 => "M&#46;R&#46; Wood"
                            4 => "M&#46; Law"
                            5 => "M&#46; Yeager"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1128/JVI.00526-10"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Virol"
                        "fecha" => "2010"
                        "volumen" => "84"
                        "paginaInicial" => "10999"
                        "paginaFinal" => "11009"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20686033"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:3 [
                  "comentario" => "&#91;accessed 1 Dec 2017&#93; Available in&#58; http&#58;&#47;&#47;www&#46;ncbi&#46;nlm&#46;nih&#46;gov&#47;pubmed&#47;1649402"
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Transmission of hepatitis C virus by organ transplantation"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "B&#46;J&#46;G&#46; Pereira"
                            1 => "E&#46;L&#46; Milford"
                            2 => "R&#46;L&#46; Kirkman"
                            3 => "A&#46;S&#46; Levey"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJM199108153250702"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "1991"
                        "volumen" => "325"
                        "paginaInicial" => "454"
                        "paginaFinal" => "460"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1649402"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Transplanting hepatitis C-positive kidneys"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "P&#46;P&#46; Reese"
                            1 => "P&#46;L&#46; Abt"
                            2 => "E&#46;A&#46; Blumberg"
                            3 => "D&#46;S&#46; Goldberg"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMp1505074"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2015"
                        "volumen" => "373"
                        "paginaInicial" => "303"
                        "paginaFinal" => "305"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26200976"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Organizaci&#243;n Nacional de Trasplantes&#46; Dossier de actividad de trasplante renal Espa&#241;a 2016&#46; 2016&#59;1&#58;1&#8211;51&#46;"
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Transplantation of kidneys from donors with hepatitis C antibody into recipients with pre-transplantation anti-HCV"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46;M&#46; Morales"
                            1 => "J&#46;M&#46; Campistol"
                            2 => "G&#46; Castellano"
                            3 => "A&#46; Andres"
                            4 => "F&#46; Colina"
                            5 => "A&#46; Fuertes"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:7 [
                        "tituloSerie" => "Kidney Int"
                        "fecha" => "1995"
                        "volumen" => "47"
                        "paginaInicial" => "236"
                        "paginaFinal" => "240"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7537343"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S0049017213002011"
                          "estado" => "S300"
                          "issn" => "00490172"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Pharmacokinetics&#44; safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "A&#46; Desnoyer"
                            1 => "D&#46; Pospai"
                            2 => "M&#46;P&#46; Le"
                            3 => "A&#46; Gervais"
                            4 => "A&#46; Heurgue-Berlot"
                            5 => "A&#46; Laradi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jhep.2016.02.044"
                      "Revista" => array:7 [
                        "tituloSerie" => "J Hepatol"
                        "fecha" => "2016"
                        "volumen" => "65"
                        "paginaInicial" => "40"
                        "paginaFinal" => "47"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26952005"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S0140673612610794"
                          "estado" => "S300"
                          "issn" => "01406736"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The American Society of Transplantation Consensus Conference on the use of hepatitis C viremic donors in solid organ transplantation"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "J&#46; Levitsky"
                            1 => "R&#46;N&#46; Formica"
                            2 => "R&#46;D&#46; Bloom"
                            3 => "M&#46; Charlton"
                            4 => "M&#46; Curry"
                            5 => "J&#46; Friedewald"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/ajt.14381"
                      "Revista" => array:7 [
                        "tituloSerie" => "Am J Transplant"
                        "fecha" => "2017"
                        "volumen" => "17"
                        "paginaInicial" => "2790"
                        "paginaFinal" => "2802"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28556422"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S0049017210002519"
                          "estado" => "S300"
                          "issn" => "00490172"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:3 [
                  "comentario" => "Available in&#58; https&#58;&#47;&#47;doi&#46;org&#47;10&#46;1016&#47;S0168-8278&#40;17&#41;30269-6"
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "EXPEDITION-I&#58; efficacy and safety of glecaprevir&#47;pibrentasvir in adults with chronic hepatitis C virus genotype 1&#44; 2&#44; 4&#44; 5 or 6 infection and compensated cirrhosis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "X&#46; Forns"
                            1 => "S&#46; Lee"
                            2 => "J&#46; Valdes"
                            3 => "S&#46; Lens"
                            4 => "R&#46; Ghalib"
                            5 => "H&#46; Aguilar"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "J Hepatol"
                        "fecha" => "2017"
                        "volumen" => "66"
                        "paginaInicial" => "S3"
                        "paginaFinal" => "S4"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "EXPANDER-1&#58; exploring renal transplants using hepatitis-C infected donors for HCV-negative recipients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "C&#46; Durand"
                            1 => "D&#46; Brown"
                            2 => "R&#46; Wesson"
                            3 => "N&#46; Bhair"
                            4 => "F&#46; Naqvi"
                            5 => "D&#46; Ostrander"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:4 [
                        "tituloSerie" => "Am J Transplant"
                        "fecha" => "2017"
                        "volumen" => "17"
                        "paginaInicial" => "207"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Trial of transplantation of HCV-infected kidneys into uninfected recipients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "D&#46;S&#46; Goldberg"
                            1 => "P&#46;L&#46; Abt"
                            2 => "E&#46;A&#46; Blumberg"
                            3 => "V&#46;M&#46; van Deerlin"
                            4 => "M&#46; Levine"
                            5 => "K&#46;R&#46; Reddy"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMc1705221"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2017"
                        "volumen" => "376"
                        "paginaInicial" => "2394"
                        "paginaFinal" => "2395"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28459186"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/20132514/0000003800000006/v1_201812140610/S2013251418301445/v1_201812140610/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "35436"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Letters to the Editor"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/20132514/0000003800000006/v1_201812140610/S2013251418301445/v1_201812140610/en/main.pdf?idApp=UINPBA000064&text.app=https://revistanefrologia.com/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2013251418301445?idApp=UINPBA000064"
]
Share
Journal Information
Vol. 38. Issue. 6.November - December 2018
Pages 573-680
Vol. 38. Issue. 6.November - December 2018
Pages 573-680
Letter to the Editor
Open Access
Transplantation of hepatitis C infected kidneys into uninfected recipients. Why not?
Trasplantar receptores hepatitis C negativos con riñones de donantes seropositivos. ¿Por qué no?
Visits
4694
Antonio Francoa,
Corresponding author
franco_ant@gva.es

Corresponding author.
, Noelia Balibreaa, Angelina Gimenob, Esperanza Merinoc, Maria Isabel Lopeza, Carlos Santiagoa, Francisco Perez Contrerasa
a Servicio de Nefrología, Hospital General Universitario Alicante, Alicante, Spain
b Servicio de Microbiología, Hospital General Universitario Alicante, Alicante, Spain
c Servicio de Medicina Interna, Hospital General Universitario Alicante, Alicante, Spain
This item has received

Under a Creative Commons license
Article information
Full Text
Bibliography
Download PDF
Statistics
Tables (1)
Table 1. Action protocol.
Full Text

The enemy to beat is the hepatitis C virus (HCV), a RNA virus of 30–38nm in size with icosahedral coat. It is a Hepacivirus of the Flaviviridae family, which has 7 genotypes.1 Its transmission is parenteral, therefore its transmission through transplanted organs has been well documented and it causes acute and chronic hepatitis.2 Given this risk, transplant from donors with antibodies against HCV has been totally contraindicated in noninfected recipients. It is estimated that more than 500 high quality kidney grafts are discarded annually in the USA for this reason.3 In 2016 we did not transplanted 15 kidneys for this reason.4. A number of organs could be transplanted to recipients infected with HCV.5 The efficacy of direct-acting antivirals eliminated HCV patients from the waiting lists6 making possible the use these organs, in a society clearly need them.4

At present we have tools to change this panorama that have been clearly stated in the Hepatitis C Consensus Conference of the American Society of Transplantion.7

The risk of HCV transmission must be defined; there is a clear distinction between donor carrying antibodies, not necessarily infectious, and the patient with viraemia that is infective. To carry out this separation, we use the Xpert® HCV Viral Load test with the Cepheid GeneXpert® system (distributed by Werfen), available in our hospital, that quantifies the viral load in 1h which allows the quick identification of the infective donor.

The efficacy, safety and tolerability of direct antivirals make feasible the transplantation of viraemic donors in seronegative recipients. Even more now with the current commercialization of the compounds glecaprevir and pibrentasvir effective against all genotypes, so there is no need to identify the genotype of the donor and are not contraindicated in renal failure, which allows its use in the peritransplant period.8

Having these tools and the successful experiences by Durand et al.9 and Goldberg et al.10 this year, we requested an ethical evaluation to implement an action protocol (Table 1) to the bioethics committee of our hospital, which gave its approval on July 18, 2017 and stressed the importance of explaining to the recipient the procedure for the subsequent signing of an informed consent.

Table 1.

Action protocol.

Donor to include: 
Carriers of HCV antibodies 
No drug addiction or institutionalization 
Rapid assessment of viral load 
Absent viral load: acting group 1 
Viral load present: action group 2 
Recipients to include: 
Individualization 
Personal interview 
Signing of an informed consent 
Action to follow: 
Action 1: considered non-infective 
Standard renal TX 
Biweekly viral load quantification/3 months 
Positive 
Glecaprevir 300mg 
Pibrentasvir 120mg/12 weeks 
Negative: no treatment 
Action 2: considered infective 
Pre-tx and post-tx 
or Glecaprevir 300mg 
or Pibrentasvir 120mg/12 weeks 

In the application of the protocol of action (Table 1), we transplanted 2 seronegative male HCV recipients of 45 and 58 years with grafts from a 40-year-old female donor and a 57-year-old male both seropositive, but with negative viral load, for what we apply the action 1. The patients today are carriers of a functioning graft and the viral load in them has been repeatedly negative.

Our initial experience, endorsed by other teams, should encourage the extensive, albeit meticulous, use of this type of donors and lead us to the conclusion that HCV, the enemy to beat, is very likely beaten.

References
[1]
P. Gastaminza, K.A. Dryden, B. Boyd, M.R. Wood, M. Law, M. Yeager, et al.
Ultrastructural and biophysical characterization of hepatitis C virus particles produced in cell culture.
J Virol, 84 (2010), pp. 10999-11009
[accessed 1 Dec 2017] Available in: http://jvi.asm.org/cgi/doi/10.1128/JVI. 00526-10
[2]
B.J.G. Pereira, E.L. Milford, R.L. Kirkman, A.S. Levey.
Transmission of hepatitis C virus by organ transplantation.
N Engl J Med, 325 (1991), pp. 454-460
[accessed 1 Dec 2017] Available in: http://www.ncbi.nlm.nih.gov/pubmed/1649402
[3]
P.P. Reese, P.L. Abt, E.A. Blumberg, D.S. Goldberg.
Transplanting hepatitis C-positive kidneys.
N Engl J Med, 373 (2015), pp. 303-305
[4]
Organización Nacional de Trasplantes. Dossier de actividad de trasplante renal España 2016. 2016;1:1–51.
[5]
J.M. Morales, J.M. Campistol, G. Castellano, A. Andres, F. Colina, A. Fuertes, et al.
Transplantation of kidneys from donors with hepatitis C antibody into recipients with pre-transplantation anti-HCV.
Kidney Int, 47 (1995), pp. 236-240
[6]
A. Desnoyer, D. Pospai, M.P. Le, A. Gervais, A. Heurgue-Berlot, A. Laradi, et al.
Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C.
J Hepatol, 65 (2016), pp. 40-47
[7]
J. Levitsky, R.N. Formica, R.D. Bloom, M. Charlton, M. Curry, J. Friedewald, et al.
The American Society of Transplantation Consensus Conference on the use of hepatitis C viremic donors in solid organ transplantation.
Am J Transplant, 17 (2017), pp. 2790-2802
[8]
X. Forns, S. Lee, J. Valdes, S. Lens, R. Ghalib, H. Aguilar, et al.
EXPEDITION-I: efficacy and safety of glecaprevir/pibrentasvir in adults with chronic hepatitis C virus genotype 1, 2, 4, 5 or 6 infection and compensated cirrhosis.
J Hepatol, 66 (2017), pp. S3-S4
Available in: https://doi.org/10.1016/S0168-8278(17)30269-6
[9]
C. Durand, D. Brown, R. Wesson, N. Bhair, F. Naqvi, D. Ostrander, et al.
EXPANDER-1: exploring renal transplants using hepatitis-C infected donors for HCV-negative recipients.
Am J Transplant, 17 (2017), pp. 207
[10]
D.S. Goldberg, P.L. Abt, E.A. Blumberg, V.M. van Deerlin, M. Levine, K.R. Reddy, et al.
Trial of transplantation of HCV-infected kidneys into uninfected recipients.
N Engl J Med, 376 (2017), pp. 2394-2395

Please cite this article as: Franco A, Balibrea N, Gimeno A, Merino E, Lopez MI, Santiago C, et al. Trasplantar receptores hepatitis C negativos con riñones de donantes seropositivos. ¿Por qué no? Nefrologia. 2018. https://doi.org/10.1016/j.nefro.2018.04.005

Copyright © 2018. Sociedad Española de Nefrología
Download PDF
Idiomas
Nefrología (English Edition)
Article options
Tools